Price movement over the last 24 hours
Align Technology, Inc. vs State Street SPDR Bloomberg Invstmt Gr Fltg Rt ETF — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while State Street SPDR Bloomberg Invstmt Gr Fltg Rt ETF trades at $30.8. Which is the better fit depends on your goals.
| ALGN | FLRN | |
|---|---|---|
Market Cap | $12.86B | — |
Sector | Health | Sector/Thematic |
52-Week High | $207.19 | $30.86 |
52-Week Low | $124.88 | $30.65 |
Enterprise Value | $11.92B | — |
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
FLRN, the SPDR Bloomberg Investment Grade Floating Rate ETF, trades at $30.80, showing minimal daily movement. The technical outlook is bearish based on moving averages, while oscillators are neutral. Recent news highlights institutional buying interest amid a rising rate environment, positioning FLRN as a potential hedge against inflation. The ETF pays consistent dividends, with recent distributions of $0.11 per share.
FLRN's outlook is shaped by its role in a higher-for-longer rate climate, offering floating-rate bond exposure that may outperform traditional fixed-income ETFs. Key risks include interest rate volatility and inflation trends. Institutional accumulation signals confidence, but the bearish technical trend warrants caution for near-term price action.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →FLRN invests in U.S. dollar-denominated investment-grade floating rate notes with maturities under five years. It provides exposure to corporate and supranational debt whose interest payments adjust with market rates, helping to mitigate interest rate risk.
Read more on FLRN →